Allergan (AGN) and Editas Tie Up to Treat Eye Diseases – Yahoo Finance
MedCity News |
Allergan (AGN) and Editas Tie Up to Treat Eye Diseases
Yahoo Finance The agreement includes early stage, first-in-class ocular programs targeting serious diseases based on Editas Medicine’s CRISPR genome editing platform, including CRISPR/Cas9 and CRISPR/Cpf1. CRISPR (Clustered Regularly Interspaced Short … Allergan and Editas announce $90M CRISPR dealMedCity News Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing …GlobeNewswire (press release) Editas, Allergan Ink $90M CRISPR-Based Eye Drug DealGenomeWeb Labiotech.eu (blog) all 109 news articles » |
CBS News |
Doctors say Florida stem cell clinic left 3 women blind
CBS News Scientists have long studied the use of stem cells, including those taken from a patient’s own body, for treating vision problems and a variety of other diseases. But they and regulators have also issued warnings about clinics that offer unproven stem … Botched stem cell treatment blinds threeThe San Diego Union-Tribune Experimental stem cell treatment stabilizes macular degenerationCNN 3 cases of blindness raise questions about stem cell clinicsSan Francisco Chronicle ABC News –Science Magazine –STAT –The New England Journal of Medicine all 65 news articles » |
|
Stem–Cell Clinic’s Treatments Left Three Patients Blind, Doctors Say
Wall Street Journal (subscription) Three patients who underwent what they believed were stem–cell treatments for macular degeneration lost their vision as a result of the procedures at a Florida clinic, according to doctors who treated the patients afterward. The cases underscore the … |
